Chris Cann Email & Phone Number

Chris Cann Work

• Chief Operating Officer @ Zydus Therapeutics (December 2021 - Present)
• VP, NASH Strategic Marketing @ Intercept Pharmaceuticals (July 2018 - December 2021)
• VP Marketing @ Sanofi (May 2015 - June 2018)
  View Department
• Head, SaxaDapa Franchise, GPPS @ AstraZeneca (February 2014 - April 2015)
• VP, Global Commercial Lead, Amylin Integration and BMS Diabetes Divestiture @ Bristol Myers Squibb (January 2012 - January 2014)
• VP, Global Brand Lead, Onglyza Franchise, Global Commercialization @ Bristol Myers Squibb (January 2009 - December 2011)
• VP, Disease Area Lead, Metabolic Franchise @ Bristol Myers Squibb (January 2006 - December 2008)
• VP, Diabetes Marketing, US Pharmaceuticals @ Bristol Myers Squibb (October 2004 - December 2005)
• Senior Director, CV Marketing, US Pharmaceuticals @ Bristol Myers Squibb (January 2001 - September 2004)
• Senior Director, CV and Metabolic Franchise, International Region @ Bristol Myers Squibb (April 1998 - December 2000)
• Franchise Director, Cholesterol and Head, Payor Marketing @ Bristol Myers Squibb (April 1996 - December 1997)
• Regional Business Director @ Merck (January 1994 - January 1996)
  View Department
• National Sales Manager, Specialty and Institutions Division @ Merck (January 1993 - January 1994)
• Marketing, CV and Metabolic Franchise @ Merck (January 1989 - January 1992)
• Sales Representative @ Merck (January 1987 - January 1989)
  View Department